SEC 13F Intelligence

Redwood Investments, LLC / CSTL

Redwood Investments, LLC’s Castle Biosciences Inc Position

Does Redwood Investments, LLC own Castle Biosciences Inc (CSTL)? Not currently — the last reported position was 375.9K shares worth $17M in Q1 2022; the fund’s latest 13F (Q1 2025) no longer reports it.

Position Value
$17M
Q1 2022
Shares
375.9K
% of Portfolio
+1.60%
Quarters Held
8
position exited

Position History CSTL

Reported value by quarter
Q2 ’20: $3MQ2 ’20Q3 ’20: $18MQ3 ’20Q4 ’20: $21MQ4 ’20Q1 ’21: $13MQ1 ’21Q2 ’21: $14MQ2 ’21Q3 ’21: $12MQ3 ’21Q4 ’21: $7MQ4 ’21Q1 ’22: $17MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2022375.9K$17M+1.60%
Q4 2021173.8K$7M+0.59%
Q3 2021175.7K$12M+0.98%
Q2 2021186.5K$14M+1.10%
Q1 2021186.7K$13M+1.12%
Q4 2020313.1K$21M+1.79%
Q3 2020353.6K$18M+1.53%
Q2 202066.5K$3M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Redwood Investments, LLC’s full portfolio or all institutional holders of CSTL.